What is it about?
Retrospective Chart Review: The Feasibility of a Self-Administered Nasal Spray
Featured Image
Photo by Usman Yousaf on Unsplash
Why is it important?
To describe the results of a self-administered anesthetic nasal spray developed to target the sphenopalatine ganglion (SPG) for the acute and preventive treatment of chronic migraine.
Perspectives
To describe the results of a self-administered anesthetic nasal spray developed to target the sphenopalatine ganglion (SPG) for the acute and preventive treatment of chronic migraine.
Acquire Publications
Read the Original
This page is a summary of: Retrospective Chart Review: The Feasibility of a Self-Administered Nasal Spray Targeting the Sphenopalatine Ganglion (SPG) in Treatment of Chronic Migraine., Journal of Anesthesia and Anesthetic Drugs, April 2022, Acquire Publications LLC,
DOI: 10.54289/jaad2200105.
You can read the full text:
Resources
Contributors
The following have contributed to this page







